Western Health

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Hepatitis B2 trials
• Ulcerative colitis2 trials
• Crohn's disease1 trial
• Hepatitis C1 trial

Phase

• Phase 23 trials
• Phase 11 trial
• Phase 2/31 trial

Status

• Active, not recruiting3 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC4 trials
• Aligos Therapeutics1 trial
• Kirby Institute1 trial

Running trials

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT05242484· Phase 2· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT05242471· Phase 2· Janssen Research & Development, LLC· Source

• Recruiting

  The Australian HCV Point-of-Care Testing Program

  NCT05042544· Kirby Institute· Source

  Contact: Nhung Duong

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hepatitis C1 recruiting

Closed trials

• Completed

  A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

  NCT04536337· Phase 1· Aligos Therapeutics· Source

• Completed

  A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus

  NCT04535544· Phase 2· Janssen Research & Development, LLC· Source